NCT05443178View on ClinicalTrials.gov

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

PHASE1RecruitingINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

October 4, 2024

Study Completion Date

June 1, 2025

Conditions

Tuberculosis Infection

Interventions

DRUG

Nivaquine ® (Chloroquine)

dose escalation and extension trial

Trial Locations (1)

8091

RECRUITING

Clinical Trial Center, Zurich

All Listed Sponsors

lead

University of Zurich

OTHER